Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 112.79B | 112.79B | 112.04B | 105.16B | 98.82B | 92.94B |
Gross Profit | 15.07B | 15.07B | 17.14B | 15.23B | 15.08B | 14.02B |
EBITDA | 6.37B | 6.92B | 10.50B | 8.41B | 9.00B | 8.37B |
Net Income | -4.19B | -4.19B | 1.75B | 399.00M | 621.00M | 300.00M |
Balance Sheet | ||||||
Total Assets | 122.34B | 122.34B | 119.46B | 113.77B | 114.38B | 113.73B |
Cash, Cash Equivalents and Short-Term Investments | 19.95B | 19.95B | 21.11B | 16.95B | 20.25B | 21.31B |
Total Debt | 26.11B | 26.11B | 22.68B | 22.81B | 25.46B | 28.34B |
Total Liabilities | 53.05B | 53.05B | 46.87B | 46.69B | 48.08B | 49.39B |
Stockholders Equity | 68.67B | 68.67B | 72.01B | 66.58B | 65.79B | 63.73B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -3.82B | 4.62B | 200.00M | 2.49B | 559.00M |
Operating Cash Flow | 0.00 | 6.25B | 10.74B | 5.87B | 7.10B | 5.64B |
Investing Cash Flow | 0.00 | -10.20B | -6.22B | -5.84B | -4.72B | -5.13B |
Financing Cash Flow | 0.00 | 2.07B | -1.01B | -4.03B | -3.73B | 8.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥34.49B | 6.96 | 3.62% | 1.00% | 413.42% | ||
74 Outperform | ¥12.79B | 5.09 | 3.66% | 0.85% | 94.79% | ||
61 Neutral | $17.97B | 12.87 | -5.29% | 2.97% | 1.26% | -14.45% | |
58 Neutral | ¥20.13B | ― | 2.82% | 2.93% | -349.98% | ||
56 Neutral | ¥9.42B | ― | 2.50% | -3.20% | -454.63% | ||
55 Neutral | ¥17.96B | 7.96 | 2.58% | -7.01% | -108.77% | ||
55 Neutral | ¥24.07B | ― | 3.11% | -4.86% | -162.41% |